Log In | Register
As someone deeply immersed in pharma communications, and especially the newer realm of social networking, I've been closely following the ongoing process of the industry/FDA dance, trying to figure out how social media/web 2.0 approaches "fit" with pharmaceutical manufacturers and their various audiences.
And I keep wondering if we're going about the whole thing the wrong way.
Think about the fine print PI (Product Information) you see in a magazine, accompanying a prescription drug ad. How many people do you think really read that? And, of that miniscule number, how many actually understand it?
How drug information fine print fails to communicate | KevinMD.com
Seeded on Sun Jun 6, 2010 11:36 PM EDT
Article Source: kevinmd.com- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
Fine print should be against the law on all products or at least considered the same as non-disclosure. How many times do we see products that have fine print that require a magnifying glass for a person with normal vision to read? Now put that product in the hands of the elderly or somewhat vision impaired and you have...NON-DISCLOSURE in my view.
#1 - Sun Jun 6, 2010 11:40 PM EDTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
